RayanaAI
Account
AXGN
HOLD / NEUTRALMeanRev
Composite
46.10
Technical
58.50
Fundamental
42.00
Rank
—
Price
49.25
Hurst
0.10
As of
Oct 29, 2026
Daily
Axogen, Inc.
HealthcareMedical Devices

Axogen develops and sells medical products for treating peripheral nerve injuries worldwide. Its product portfolio includes nerve grafts made from donated human tissue, surgical connectors and protective wraps for nerve repair, and soft tissue matrices derived from animal and human sources. The company supplies these devices to hospitals and surgical centers through distributors, primarily serving plastic surgeons, orthopedic specialists, and hand surgeons.

Market cap
$2.9B
P/E (trailing)
—
P/E (forward)
69.98
PEG ratio
99.04
Dividend yield
0.00%
Beta
1.17
52w range
21.93 – 52.91
Return on equity
-10.35%
Profit margin
-11.96%
Revenue growth
+26.20%
Earnings growth
+300.00%
Price history

1Y: 49.37 (+122.2%) · range 22.22–51.73

Cycle position
62/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 28 · NOT READY · exit proximity 50

Conviction
40/ 100 · maturity 29%
VScore.1613
Buildup.2870
EMA entry setup.3528
Fundamentals.2142
Volume profile
POC
44.45
Price vs POC
+11.1%
Overhead supply
7%
Runway
open sky

Value area 37.87–46.89 · 7% of 120d volume overhead · clean runway

Contributing sources
SourceScoreLast seen
earnings-surprise
0.933
Oct 30, 2026
Forward returns
HorizonReturnMFEState
20d+25.10%+25.10%mature
40d+4.93%+25.10%mature